The FDA and designing clinical trials for chronic cutaneous ulcers

Seminars in Cell and Developmental Biology

Volumn 23, Issue 9, 2012, Pages 993-999

  Maderal, Andrea D ^a   Vivas, Alejandra C ^a   Eaglstein, William H ^a   Kirsner, Robert S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic wound; Clinical trial; Diabetic foot ulcer; Food and Drug Administration (FDA); Venous leg ulcer

Indexed keywords

ANTIBIOTIC AGENT; BECAPLERMIN; BETA CATENIN; HEMOGLOBIN A1C;

ANKLE BRACHIAL INDEX; AUTOIMMUNE DISEASE; CELL THERAPY; CELLULITIS; CHRONIC WOUND; CLINICAL TRIAL (TOPIC); COMPRESSION THERAPY; DEBRIDEMENT; DEVICE APPROVAL; DIABETIC FOOT; DRUG APPROVAL; EDEMA; ERYTHEMA; FEVER; FOOD AND DRUG ADMINISTRATION; FOOT ULCER; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEG ULCER; MULTICENTER STUDY (TOPIC); OFF LABEL DRUG USE; ONCOGENE C MYC; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOFT TISSUE INFECTION; STUDY DESIGN; TRANSCUTANEOUS OXYGEN MONITORING; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 84870552662     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.09.014     Document Type: Review

References (42)

1. Development and approval process (drugs). [accessed 31.03.12]. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm.
2. Drugs@FDA glossary of terms. [accessed 25.04.12]. http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm%3Futm_campaign=Google2%26utm_source=fdaSearch%26utm_medium=website%26utm_term=definition%20drug%26utm_content=1%23D.
3. Is the product a medical device? [accessed 25.04.12]. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051512.htm%3Futm_campaign=Google2%26utm_source=fdaSearch%26utm_medium=website%26utm_term=definition%20medical%20device%26utm_content=1.
4. FDA medical device approval process. [accessed 25.04.12]. http://www.mannfbe.org/commercialize/approval-process.htm.
5. FDA: 35 innovated new drugs approved in fiscal year. [accessed 26.04.12]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278383.htm.
6. Wieman T.J., Smiell J.M., Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 1998, 21(5):822-827.
7. Veves A., Falanga V., Armstrong D.G., Sabolinski M.L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001, 24(2):290-295. Apligraf Diabetic Foot Ulcer Study.
8. Marston W.A., Hanft J., Norwood P., Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers. Diabetes Care 2003, 26(6):1701-1705. Dermagraft Diabetic Foot Ulcer Study Group.
9. Vivas A.C., Maderal A.D., Than M.P., Kirsner R.S. Letter: designing clinical trials to bring wound products to market. International Wound Journal 2011, [Epub ahead of print]. 10.1111/j.1742-481X.2011.00907.x.
10. FDA Wound Healing Clinical Focus Group Guidance for industry: chronic cutaneous ulcer and burn wounds - developing products for treatment. Wound Repair and Regeneration 2001, 9(4):258-268.
11. Gottrup F., Apelqvist J., Price P. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. Journal of Wound Care 2010, 19(6):237-268. European Wound Management Association Patient Outcome Group.
12. Sheehan P., Jones P., Caselli A., Giurini J.M., Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003, 26(6):1879-1882.
13. Charles C.A., Tomic-Canic M., Vincek V., Nassiri M., Stojadinovic O., Eaglstein W.H., et al. A gene signature of nonhealing venous ulcers: potential diagnostic markers. Journal of the American Academy Dermatology 2008, 59(5):758-771.
14. Stojadinovic O., Brem H., Vouthounis C., Lee B., Fallon J., Stallcup M., et al. Molecular pathogenesis of chronic wounds: the role of Beta-catenin and c-myc in the inhibition of epithelialization and wound healing. American Journal of Pathology 2005, 167(1):59-69.
15. O'Connor NR. Diabetes mellitus (type 2). Essential evidence plus. Updated April 30, 2012 [accessed 20.06.12]. http://www.essentialevidenceplus.com/content/eee/127%3Fsection=6.
16. Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, MA. American Diabetes Association. Diabetes Care 1999, 22(8):1354-1360.
17. Lavery L.A., Vela S.A., Lavery D.C., Quebedeaux T.L. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations: a comparison of treatments. Diabetes Care 1996, 19(8):818-821.
18. Armstrong D.G., Nguyen H.C., Lavery L.A., van Schie C.H., Boulton A.J., Harkless L.B. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001, 24(6):1019-1022.
19. Mueller M.J., Diamond J.E., Sinacore D.R., Delitto A., Blair V.P., Drury D.A., et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989, 12(6):384-388.
20. Armstrong D.G., Lavery L.A., Kimbriel H.R., Nixon B.P., Boulton A.J. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003, 26(9):2595-2597.
21. Armstrong D.G., Short B., Nixon B.P., Boulton A.J.M. Technique for fabrication of an "instant" total contact cast for treatment of neuropathic diabetic foot ulcers. Journal of the American Podiatric Medical Association 2002, 92(7):405-408.
22. Armstrong D.G., Lavery L.A., Wu S., Boulton A.J. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005, 28(3):551-554.
23. Steed D.L., Donohoe D., Webster M.W., Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Journal of American College of Surgeon 1996, 183(1):61-64. Diabetic Ulcer Study Group.
24. Golinko M.S., Joffe R., Maggi J., Cox D., Chandrasekaran E.B., Tomic-Canic R.M., et al. Operative debridement of diabetic foot ulcers. Journal of American College Surgery 2008, 207(6):e1-e6.
25. Moffatt C. Compression therapy in practice 2007, Wounds UK Publishing, Trowbridge.
26. Cullum N., Nelson E.A., Flemming K., Sheldon T. Systematic reviews of wound care management: (5) beds; (6) compression; (7): laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. Health Technology Assessment 2001, 5(9):1-221.
27. Marston W, Vowden K. Compression therapy: a guide to safe practice. In: European Wound Management Association (EWMA). Position Document. Understanding Compression Therapy. London: MEP Ltd, 2003; 11-6. Available from URL: http://www.ewma.org/.
28. Partsch H. Compression therapy of venous ulcers. Management of leg ulcers (current problems in dermatology) 1999, Vol. 27:130-140. Karger, Basel.
29. Moffatt C., Martin R., Smithdale R. Leg ulcer management 2007, Blackwell Publishing Ltd, Oxford.
30. Coull A., Tolson D., McIntosh J. Class-3c compression bandaging for venous ulcers: comparison of spiral and figure-of-eight techniques. Journal of Advanced Nursing 2006, 54(3):274-283.
31. Thomas S., Fram P. An evaluation of a new type of compression bandaging system. World Wide Wounds 2003, 1-14. [accessed 14.05.12]. http://www.worldwidewounds.com/2003/September/Thomas/New-Compression-Bandage.html.
32. Callam M.J., Ruckley C.V., Dale J.J., Harper D.R. Hazards of compression treatment of the leg: an estimate from Scottish surgeons. British Medical Journal (Clinical Research Edition) 1987, 295(6610):1382.
33. Partsch H., Vanscheidt W. Variability of interface pressure exerted by compression bandages and standard size compression stockings. Presented at AVF 2008.
34. O'Meara S., Tierney J., Cullum N., Bland J.M., Franks P.J., Mole T., et al. Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients. British Medical Journal 2009, 338:b1344.
35. Labropoulos N., Wang E.D., Lanier S.T., Khan S.U. Factors associated with poor healing and recurrence of venous ulceration. Plastic and Reconstructive Surgery 2012, 129(1):179-186.
36. Williams D., Enoch S., Miller D., Harris K., Price P., Harding K.G. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair and Regeneration 2005, 13(2):131-137.
37. Cardinal M., Eisenbud D.E., Armstrong D.G., Zelen C., Driver V., Attinger C., et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair and Regeneration 2009, 17(3):306-311.
38. Mostow E.N., Haraway G.D., Dalsing M., Hodde J.P., King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial. Journal of Vascular Surgery 2005, 41(5):837-843. OASIS Venous Ulcer Study Group.
39. Hunt J.A. Foot infections in diabetes are rarely due to a single microorganism. Diabetic Medicine 1992, 9(8):749-752.
40. Robson M.C., Cooper D.M., Aslam R., Gould L.J., Harding K.G., Margolis D.J., et al. Guidelines for the treatment of venous ulcers. Wound Repair and Regeneration 2006, 14(6):649-662.
41. Stromberg K., Chapekar M.S., Goldman B.A., Chambers W.A., Cavagnaro J.A. Regulatory concerns in the development of topical recombinant ophthalmic and cutaneous wound healing biologics. Wound Repair and Regeneration 1994, 2(3):155-164.
42. Robson M.C., Maggi S.P., Smith P.D., Wassermann R.J., Mosiello G.C., Hill D.P., et al. Original articles: ease of wound closure as an endpoint of treatment efficacy. Wound Repair and Regeneration 1999, 7(2):90-96.